share_log

4: Statement of changes in beneficial ownership of securities-Director TOOVEY STEPHEN

4: Statement of changes in beneficial ownership of securities-Director TOOVEY STEPHEN

4:持股變動聲明-董事 TOOVEY STEPHEN
美股SEC公告 ·  05/21 20:25

Moomoo AI 已提取核心訊息

Stephen Toovey, reported a purchase of 4,000 shares of 60 Degrees Pharmaceuticals (SXTP) common stock on May 16, 2024. The transaction was completed at a price of $0.223 per share. Following this acquisition, Toovey's direct holdings in the company increased to a total of 14,000 shares. The transaction, described as a grant, award, or other acquisition, reflects Toovey's growing stake in the pharmaceutical company.
Stephen Toovey, reported a purchase of 4,000 shares of 60 Degrees Pharmaceuticals (SXTP) common stock on May 16, 2024. The transaction was completed at a price of $0.223 per share. Following this acquisition, Toovey's direct holdings in the company increased to a total of 14,000 shares. The transaction, described as a grant, award, or other acquisition, reflects Toovey's growing stake in the pharmaceutical company.
斯蒂芬·圖維報告說,2024年5月16日購買了4,000股60度製藥(SXTP)普通股。該交易以每股0.223美元的價格完成。此次收購後,Toovey在該公司的直接持股量增加到總共14,000股。該交易被描述爲贈款、獎勵或其他收購,反映了Toovey在這家制藥公司的股份不斷增加。
斯蒂芬·圖維報告說,2024年5月16日購買了4,000股60度製藥(SXTP)普通股。該交易以每股0.223美元的價格完成。此次收購後,Toovey在該公司的直接持股量增加到總共14,000股。該交易被描述爲贈款、獎勵或其他收購,反映了Toovey在這家制藥公司的股份不斷增加。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息